Aantal uitgiftes per gebruiker 2019-2023 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 2,35 | 3,57 | 4,21 | 3,28 | 4,31 |
| J05AF05 Lamivudine (Epivir ®) | 5,66 | 5,71 | 5,80 | 5,43 | 5,52 |
| J05AF06 Abacavir (Ziagen ®) | 6,89 | 7,12 | 6,70 | 6,79 | 7,02 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 4,49 | 4,42 | 4,46 | 4,18 | 4,22 |
| J05AF08 Adefovir | 5,14 | 5,84 | 5,98 | 6,36 | 2,50 |
| J05AF09 Emtricitabine (Emtriva ®) | 5,44 | 5,62 | 5,09 | 4,85 | 4,45 |
| J05AF10 Entecavir (Baraclude ®) | 5,64 | 5,47 | 5,33 | 5,43 | 5,40 |
| J05AF11 Telbivudine | 3,57 | 1,50 | . | . | . |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | 5,31 | 5,72 | 5,80 | 5,61 | 5,69 |